APIS ESR1 Mutations Kit

APIS ESR1 Mutations Kit (RUO*)

The APIS ESR1 Mutations Kit is an advanced qPCR assay for the sensitive and precise detection of mutations within the oestrogen receptor gene. The APIS ESR1 Mutations Kit is a qualitative test, detecting eleven ESR1 mutations across three exons: exon 5 (E380Q), exon 7 (S463P) and exon 8 (P535H, L536R, L536Q, L536H, L536P, Y537C, Y537S, Y537N and D538G).

The APIS ESR1 Mutations Kit includes mutation-specific probes to enable highly sensitive detection of the target mutations. Additionally, it uses PCR clamp and blocker technology, which ensures specific amplification of the mutant sequence, even in the presence of a high wild-type background.

*APIS ESR1 Mutations Kit is for Research Use Only (RUO), not for use in diagnostic procedures.

Download Leaflet

Download Technical Sheet

Contact Us

Benefits of Using APIS ESR1 Mutations Kit

  1. Wide target coverage • the kit has been designed to cover 11 ESR1 mutations
  2. High specificity  includes clamp and blocking technology to ensure no wild-type detection
  3. High sensitivity  all mutations are detected at ≤ 1% MAF (Mutant Allele Frequency)
  4. Easy to use • our assays are designed to be user-friendly, with a simple protocol. The reagents have been optimised for precise and sensitive detection in human DNA.

SPECIMEN REQUIREMENTS

  • 30 µl of DNA, e.g., extracted cell-free DNA (cfDNA).
  • It is recommended to extract samples using a cell-free-specific kit and to use the sample without dilution.

Assay Mutations and Analytical Sensitivity in Contrived Samples

The APIS ESR1 Mutations Kit detects 11 ESR1 mutations across three exons. Contrived samples of 0.008–1.6% mutant allele frequency (MAF) were prepared with a total copy of 5000 per reaction. A total of 24 replicates were generated per target, across two instruments and two kit lots. The Limit of Detection (LoD) is based on the highest mutant allele frequency with 95% correct calls observed for each target in the 24 replicates. The claimed LoD for the targets in % MAF is ≤ 1% for all targets (Table 1).

ESR1 APIS - table

Table 1. 11 ESR1 mutations detected in the APIS ESR1 Mutations Kit.  LoD in % MAF and copies (cp). The mutant copies at LoD and WT copies at LoD describe the copies of each DNA fragment in the contrived LoD samples.

Supporting Data for the APIS ESR1 Mutations Kit Linearity

An 8-level dilution series of DNA fragments specific to each mutation were used to evaluate PCR efficiency and R-sq values (Table 2 and Figure 1).

graphic_4.1

SPECIFICATIONS

The kit has undergone testing as part of APIS' unique assay development pipeline, which includes in silico and wet laboratory testing. As a result, researchers can have confidence in the accuracy, sensitivity, specificity, and reliability of the kit. The qPCR assay’s efficiency and linearity were assessed using contrived synthetic DNA samples.

apis_esr1_flyer_kit_specifications

Discover all Breast Cancer Assays

Breast Cancer Portfolio

breast_-_3_women.jpg